TokenPost·
AnaptysBio Shares Rise After FDA Expands Jemperli Approval
The accelerated approval adds a use for GSK’s cancer treatment in a type of rectal cancer.
More news
- TokenPostMichael Saylor Says the First $3 Billion Is the Hardest
- Crypto BriefingBlockchain Association backs Treasury stablecoin rule but wants tighter definitions
- Bitcoin.com NewsBlackrock Files for Bitcoin ETF Designed to Limit Investor Losses
- Crypto BriefingOpenAI accelerates fundraising ahead of Anthropic IPO
- TokenPostAmazon Shares Gain 4.98% on Day It Backs Proposed Indiana Nuclear Plant
- TokenPostLeveraged Funds Cut Bitcoin Futures Net Shorts by Nearly 15%